IRIS
MOAVERO, ROMINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.598
EU - Europa 1.044
AS - Asia 312
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 18.969
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.592
IE - Irlanda 240
UA - Ucraina 215
DE - Germania 160
KR - Corea 128
IT - Italia 114
CN - Cina 103
GB - Regno Unito 85
FR - Francia 74
FI - Finlandia 59
PL - Polonia 33
TW - Taiwan 33
NL - Olanda 22
JP - Giappone 16
SE - Svezia 14
RU - Federazione Russa 13
IN - India 6
CA - Canada 5
EU - Europa 5
VN - Vietnam 5
BR - Brasile 4
HK - Hong Kong 4
ES - Italia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
IR - Iran 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
RO - Romania 2
SA - Arabia Saudita 2
SG - Singapore 2
SM - San Marino 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
GR - Grecia 1
MO - Macao, regione amministrativa speciale della Cina 1
PT - Portogallo 1
Totale 18.969
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.448
Wilmington 4.799
Houston 3.878
Fairfield 762
Ann Arbor 415
Chandler 323
Seattle 312
Ashburn 298
Cambridge 239
Dublin 229
Jacksonville 184
Medford 179
Dearborn 98
Lawrence 89
Beijing 61
New York 60
Rome 41
Menlo Park 40
Norwalk 36
Kraków 33
Taipei 33
San Diego 32
Mülheim 16
London 15
Redwood City 13
Lappeenranta 10
Milan 9
Redmond 8
Seoul 8
University Center 8
Falls Church 7
Mountain View 7
Saint Petersburg 7
Nanjing 6
Verona 6
Jinan 5
Kunming 5
San Mateo 5
Boardman 4
Chiswick 4
Dronten 4
Phoenix 4
Prescot 4
University Park 4
Catania 3
Cernay 3
Chiyoda-ku 3
Fleet 3
Guangzhou 3
Hanoi 3
Hefei 3
Helsinki 3
Indiana 3
Kilburn 3
São Paulo 3
Zhengzhou 3
Amsterdam 2
Beirut 2
Colombo 2
Domagnano 2
Dong Ket 2
Hangzhou 2
Hounslow 2
Hyderabad 2
Kuala Lumpur 2
Lima 2
Mercer Island 2
Nanchang 2
Navi Mumbai 2
New Bedfont 2
Nürnberg 2
Ottawa 2
Palermo 2
Paris 2
Parma 2
Raleigh 2
Reading 2
Rende 2
San Francisco 2
San Pietro in Lama 2
Shanghai 2
Swansea 2
Tokyo 2
Toronto 2
Waanrode 2
Acton 1
Anderson 1
Ayer 1
Baotou 1
Bari 1
Bethesda 1
Bhubaneswar 1
Blackburn 1
Bolzano 1
Bracke 1
Brasov 1
Casoria 1
Chengdu 1
Cincinnati 1
Clearwater 1
Totale 17.857
Salva come PNG Salva come JPEG
Nome #
Current role of perampanel in pediatric epilepsy 475
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 428
mTOR Inhibitors in Tuberous Sclerosis Complex. 406
Cognitive development in females with PCDH19 gene-related epilepsy 403
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 402
Current role of melatonin in pediatric neurology: Clinical recommendations 386
Peri-ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy 382
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 381
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 379
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 379
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 377
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 371
Long-term follow-up in children with benign convulsions associated with gastroenteritis 367
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 366
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 357
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 357
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 357
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 352
Syndromic autism: Causes and pathogenetic pathways 351
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 351
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 349
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 344
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 340
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 339
Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas 338
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 336
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 336
Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia 335
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. 333
The neurobiology of attention deficit/hyperactivity disorder. 333
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis. 332
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 331
MTOR inhibitors as a new therapeutic option for epilepsy 329
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. 327
Attention deficit hyperactivity disorder in children with epilepsy. 320
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study 320
Paediatric use of melatonin (Author reply to D. J. Kennaway). 318
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. 313
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. 306
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective 301
The neurobiological basis of ADHD. 300
Can we change the course of epilepsy in tuberous sclerosis complex? 291
Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State 286
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. 279
New perspectives in Autism spectrum disorder associated with tuberous sclerosis 272
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 272
Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. 271
Pharmacotherapy of idiopathic generalized epilepsies 265
Neuroimaging findings of Sturge-Weber Syndrome in a child with Tuberous Sclerosis 251
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 239
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations 238
Recent advances in neurobiology of Tuberous Sclerosis Complex 231
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) 175
mTOR dysregulation and tuberous sclerosis-related epilepsy 141
Everolimus for Retinal Astrocytic Hamartomas in Tuberous Sclerosis Complex 119
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study 115
Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study 111
Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria 111
Immediate and prolonged-release melatonin in children with neurodevelopmental disabilities. Author reply to Prof. Zisapel 107
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: A Delphi consensus report 104
Features of primary chronic headache in children and adolescents and validity of ICHD 3 criteria 104
Prophylactic treatment of pediatric migraine: Is there anything new in the last decade? 90
Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study 83
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 81
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex? 67
Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report 32
Case Report: Migralepsy: The Two-Faced Janus of Neurology 31
Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine 29
High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample 27
Autism and Epilepsy in Patients With Tuberous Sclerosis Complex 24
Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study 23
Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review 19
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review 18
Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what 17
Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns 15
Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study 15
Long-term use of {mTORC}1 inhibitors in tuberous sclerosis complex associated neurological aspects 14
Use of Nutraceutical Ingredient Combinations in the Management of Tension-Type Headaches with or without Sleep Disorders 14
Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes 13
Features and Management of New Daily Persistent Headache in Developmental-Age Patients 13
Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway 12
Truths and Myths in Pediatric Migraine and Nutrition 12
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children 12
Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge 11
How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents 11
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial 11
Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study 11
Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity? 11
Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents - A questionnaire-based study 9
Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics 9
Totale 19.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.870
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.152 0 0 0 0 0 0 0 0 0 0 540 612
2019/20205.059 412 436 343 505 432 510 407 449 440 386 358 381
2020/20213.243 348 394 391 419 273 402 400 283 68 89 142 34
2021/2022741 33 54 28 10 22 62 26 21 159 54 54 218
2022/2023867 97 90 18 82 82 236 88 36 69 3 41 25
2023/2024233 43 9 21 3 28 97 8 3 3 17 1 0
Totale 19.223